Überblick
Kris Bieker-Brady will be moderating the panel covering biologics and biosimilars at the Life Sciences Patent Network “Protecting Innovation in a Changing Landscape.” She will be discussing the differences between biosimilars and generics matter, and if biologics necessitate date exclusivity protection.
STAY AHEAD OF THE CURVE
Interested in receiving articles on similar topics as they are published? Subscribe for timely email updates or contact us to discuss more…